Drugs / PEG-paclitaxel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00023166 | May 2001 → May 2002 | lymphoma, metastatic neoplasm | Enzon Pharmaceuticals, Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-paclitaxel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00023166 ↗ |